Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hutley, L.
Right arrow Articles by Prins, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hutley, L.
Right arrow Articles by Prins, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:3097-3106, 2004
© 2004 by the American Diabetes Association, Inc.

Fibroblast Growth Factor 1

A Key Regulator of Human Adipogenesis

Louise Hutley1,2, Wenda Shurety1, Felicity Newell1, Ross McGeary3, Nicole Pelton1, Jennifer Grant1, Adrian Herington4, Donald Cameron5, Jon Whitehead1, and Johannes Prins1,2

1 Department of Diabetes and Endocrinology and University of Queensland Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia
2 Adipogen, University of Queensland, St. Lucia, Australia
3 Chemistry Department and School of Pharmacy, University of Queensland, Brisbane, Australia
4 Centre for Molecular Biotechnology, School of Life Sciences, Queensland University of Technology, Brisbane, Australia
5 Princess Alexandra Hospital Centres for Health Research, Princess Alexandra Hospital, Woolloongabba, Australia

Obesity, with its related problems, is recognized as the fastest growing disease epidemic facing the world, yet we still have limited insight into the regulation of adipose tissue mass in humans. We have previously shown that adipose-derived microvascular endothelial cells (MVECs) secrete a factor(s) that increases proliferation of human preadipocytes. We now demonstrate that coculture of human preadipocytes with MVECs significantly increases preadipocyte differentiation, evidenced by dramatically increased triacylglycerol accumulation and glycerol-3-phosphate dehydrogenase activity compared with controls. Subsequent analysis identified fibroblast growth factor (FGF)-1 as an adipogenic factor produced by MVECs. Expression of FGF-1 was demonstrated in MVECs but not in preadipocytes, while preadipocytes were shown to express FGF receptors 1–4. The proliferative effect of MVECs on human preadipocytes was blocked using a neutralizing antibody specific for FGF-1. Pharmacological inhibition of FGF-1 signaling at multiple steps inhibits preadipocyte replication and differentiation, supporting the key adipogenic role of FGF-1. We also show that 3T3-L1 cells, a highly efficient murine model of adipogenesis, express FGF-1 and, unlike human preadipocytes, display no increased differentiation potential in response to exogenous FGF-1. Conversely, FGF-1–treated human preadipocytes proliferate rapidly and differentiate with high efficiency in a manner characteristic of 3T3-L1 cells. We therefore suggest that FGF-1 is a key human adipogenic factor, and these data expand our understanding of human fat tissue growth and have significant potential for development of novel therapeutic strategies in the prevention and management of human obesity.


Address correspondencereprint requests to Dr. Louise HutleyProf. Johannes Prins, Department of DiabetesEndocrinologyUniversity of Queensland Department of Medicine, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102, Australia. E-mail: lhutley{at}soms.uq.edu.aujprins{at}soms.uq.edu.au


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. D. Sun, M. Malabunga, J. R. Tonra, R. DiRenzo, F. E. Carrick, H. Zheng, H.-R. Berthoud, O. P. McGuinness, J. Shen, P. Bohlen, et al.
Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E964 - E976.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. S. Newell, H. Su, H. Tornqvist, J. P. Whitehead, J. B. Prins, and L. J. Hutley
Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation
FASEB J, December 1, 2006; 20(14): 2615 - 2617.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. A. Richards, T. Stephens, H. K. Charlton, A. Jones, G. A. Macdonald, J. B. Prins, and J. P. Whitehead
Adiponectin Multimerization Is Dependent on Conserved Lysines in the Collagenous Domain: Evidence for Regulation of Multimerization by Alterations in Posttranslational Modifications
Mol. Endocrinol., July 1, 2006; 20(7): 1673 - 1687.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
G. J. Hausman, S. P. Poulos, R. L. Richardson, C. R. Barb, T. Andacht, H. C. Kirk, and R. L. Mynatt
Secreted proteins and genes in fetal and neonatal pig adipose tissue and stromal-vascular cells
J Anim Sci, July 1, 2006; 84(7): 1666 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. Koellensperger, D. von Heimburg, M. Markowicz, and N. Pallua
Human Serum from Platelet-Poor Plasma for the Culture of Primary Human Preadipocytes
Stem Cells, May 1, 2006; 24(5): 1218 - 1225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.